|
May 25, 2012
|
| 10:36 EDT |  | SIMO |
| theflyonthewall.com: | Silicon Motion to benefit from ramp in LTE in-house solutions, says Craig-Hallum |
 Subscribe for More Information :theflyonthewall.com |
|
|
May 24, 2012
|
| 07:49 EDT |  | ZNGA |
|
|
May 23, 2012
|
| 16:11 EDT |  | GILD |
| theflyonthewall.com: | Gilead files European Marketing Application for boosting agent cobicistat | | Gilead Sciences announced that the Marketing Authorisation Application for cobicistat, submitted on April 26, 2012, has been validated by the European Medicines Agency. Cobicistat is Gilead’s pharmacoenhancing or “boosting” agent that increases blood levels of certain commercially available protease inhibitors, including atazanavir and darunavir, in order to enable once-daily dosing. Currently, ritonavir is the only agent used to boost HIV therapy. Review of the MAA for cobicistat will be conducted under the centralized licensing procedure, which, when finalized, provides one marketing authorization in all 27 member states of the European Union. :theflyonthewall.com |
|
| 14:49 EDT | | ZNGA |
|
| 12:42 EDT | | ZNGA |
|
|
May 22, 2012
|
| 08:04 EDT | | ZNGA |
|
|
May 21, 2012
|
| 12:19 EDT |  | ZNGA |
|
| 09:01 EDT |  | ZNGA |
|
| 09:00 EDT | | ZNGA |
| theflyonthewall.com: | Zynga falls 3.9% | | Zynga is down 3.9%, or 28c, to $6.88 :theflyonthewall.com |
|
|
May 18, 2012
|
| 14:34 EDT | | ZNGA |
|
| 14:29 EDT | | ZNGA |
|
| 13:37 EDT | | ZNGA |
| theflyonthewall.com: | Zynga trading resumes, shares down 7% to $7.68 | | :theflyonthewall.com |
|
| 12:30 EDT | | ZNGA |
|
| 11:40 EDT | | ZNGA |
|
| 11:38 EDT | | ZNGA |
| theflyonthewall.com: | Zynga halted for circuit breaker after dropping 13% following Facebook IPO | | :theflyonthewall.com |
|
| 08:53 EDT | | ZNGA |
| theflyonthewall.com: | GSV Capital volatility elevated into Facebook IPO | | GSV Capital (GSVC) overall option implied volatility of 78 is above its six-week average of 64, according to Track Data, suggesting elevated movement because of the stakes it owns in Zynga (ZNGA), Facebook (FB), Twitter and 15 other blue-chip venture-backed companies. :theflyonthewall.com |
|
|
May 17, 2012
|
| 12:53 EDT | | ZNGA |
|
| 10:10 EDT |  | SIMO |
|
| 08:18 EDT | | GILD |
| theflyonthewall.com: | Gilead likey to remain dominant in HIV treatment for some time, says Wells Fargo |
Subscribe for More Information :theflyonthewall.com |
|
| 06:38 EDT | | TRMB |
|
|
May 16, 2012
|
| 10:21 EDT | | ZNGA |
|
| 10:05 EDT | | ZNGA |
| theflyonthewall.com: | Zynga seeing increasing opportunities for social games on smartphone platforms |
Subscribe for More Information :theflyonthewall.com |
|
| 10:04 EDT | | ZNGA |
| theflyonthewall.com: | Zynga CFO says EA, Disney still competitors in core social game space | | :theflyonthewall.com |
|
| 10:03 EDT | | ZNGA |
| theflyonthewall.com: | Zynga CFO says company bringing whole new class of gamers into game space | | Comment made at JPMorgan's 40th Annual Global Technology, Media & Telecom Conference. :theflyonthewall.com |
|
| 07:38 EDT | | TRMB |
|
| 04:45 EDT | | ZNGA |
|
|
May 15, 2012
|
| 08:52 EDT | | ZNGA |
|
| 07:30 EDT | | ZNGA |
| theflyonthewall.com: | Zynga management to meet with Lazard Capital | | Meeting to be held in New York on May 17 hosted by Lazard Capital. :theflyonthewall.com |
|
|
May 14, 2012
|
| 07:45 EDT | | GILD |
| theflyonthewall.com: | Gilead Quad approval will be important, says RW Baird | | Baird said Gilead received an expected FDA panel vote in favor of approving Quad. The firm believes Quad could be the most important product for the company to improve its margins and allow it to sustain its dominant franchise in the coming years. Shares are Outperform rated with a $59 price target. :theflyonthewall.com |
|
